ADIL · Adial Pharmaceuticals, Inc.
$3.29
+0.14 (+4.44%)
At close · Jul 30
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company does not believe that the existing cash and cash equivalents are sufficient to fund operations for the next twelve months following the filing of these unaudited condensed financial statements. During 2026, the Company received net proceeds of approximately $0.3 million from equity issuances. However, the Company will require additional capital to continue operations and development of AD04. These factors raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 8, 2026
Market Cap
$7.05M
Shares
2.14M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 14,453 | 400,364 | 414,817 | 60.7% |
| 2026-04-27 | 14,480 | 201,196 | 215,676 | 62.4% |
| 2026-04-20 | 28,434 | 370,436 | 398,870 | 58.6% |
| 2026-04-13 | 8,758 | 214,390 | 223,148 | 60.8% |
| 2026-04-06 | 13,183 | 311,536 | 324,719 | 54.3% |
| 2026-03-30 | 11,379 | 161,524 | 172,903 | 52.7% |
| 2026-03-23 | 9,658 | 158,865 | 168,523 | 52.7% |
| 2026-03-16 | 23,938 | 141,554 | 165,492 | 47.9% |
| 2026-03-09 | 18,412 | 163,700 | 182,112 | 49.3% |
| 2026-03-02 | 53,849 | 948,225 | 1,002,074 | 44.8% |
| 2026-02-23 | 26,396 | 150,209 | 176,605 | 55.9% |
| 2026-02-16 | 27,572 | 77,192 | 104,764 | 47.7% |
| 2026-02-09 | 29,914 | 199,771 | 229,685 | 55.8% |
| 2026-02-02 | 316,577 | 3,412,599 | 3,729,176 | 100.0% |
| 2026-01-26 | 25,319 | 849,331 | 874,650 | 100.0% |
| 2026-01-19 | 39,456 | 941,301 | 980,757 | 100.0% |
| 2026-01-12 | 50,869 | 1,028,393 | 1,079,262 | 100.0% |
| 2026-01-05 | 76,177 | 1,303,856 | 1,380,033 | 100.0% |
| 2025-12-29 | 26,421 | 1,139,984 | 1,166,405 | 100.0% |
| 2025-12-22 | 44,339 | 936,855 | 981,194 | 100.0% |
| 2025-12-15 | 58,081 | 1,412,268 | 1,470,349 | 100.0% |
| 2025-12-08 | 62,625 | 555,195 | 617,820 | 100.0% |
| 2025-12-01 | 51,611 | 558,087 | 609,698 | 100.0% |
| 2025-11-24 | 100,359 | 1,035,854 | 1,136,213 | 100.0% |
| 2025-11-17 | 117,505 | 1,421,025 | 1,538,530 | 100.0% |
| 2025-11-10 | 48,812 | 831,415 | 880,227 | 100.0% |
| 2025-11-03 | 50,465 | 893,149 | 943,614 | 100.0% |
| 2025-10-27 | 55,484 | 2,186,493 | 2,241,977 | 100.0% |
| 2025-10-20 | 137,413 | 1,521,370 | 1,658,783 | 100.0% |
| 2025-10-13 | 62,629 | 2,211,965 | 2,274,594 | 100.0% |
| 2025-10-06 | 64,096 | 3,228,004 | 3,292,100 | 100.0% |
| 2025-09-29 | 55,996 | 2,921,801 | 2,977,797 | 100.0% |
| 2025-09-22 | 32,428 | 1,739,845 | 1,772,273 | 100.0% |
| 2025-09-15 | 47,641 | 2,701,218 | 2,748,859 | 100.0% |
| 2025-09-08 | 40,454 | 1,877,331 | 1,917,785 | 100.0% |
| 2025-09-01 | 47,549 | 1,314,988 | 1,362,537 | 100.0% |
| 2025-08-25 | 47,340 | 1,385,331 | 1,432,671 | 100.0% |
| 2025-08-18 | 56,765 | 2,203,552 | 2,260,317 | 100.0% |
| 2025-08-11 | 33,706 | 2,374,311 | 2,408,017 | 100.0% |
| 2025-08-04 | 42,373 | 3,854,294 | 3,896,667 | 100.0% |
Showing 1–40 of 40 weeks
Key facts
CIK
1513525
CUSIP
00688A304
13F (30d)
30 filings
5 filers
Visit website
Investor relations